ADVERTISEMENT
Pharmacist taking a patient's blood pressure reading

Pharmacy-Based Hypertension Management

This 6-hour advanced training program is designed to equip pharmacists with the knowledge, skills, and confidence needed to perform hypertension services in their pharmacy. The program provides comprehensive instruction in current hypertension concepts and standards of care and incorporates case studies and implementation focused strategies to emphasize the situations most likely to be encountered—as well as the services most needed—in community practice settings.

Pricing
  • Member Price: $149
  • Nonmember Price: $249

If your company or organization is interested in offering this program to your pharmacists or student pharmacists, please contact Chris McKerrow.


Learning Objectives & Module Details
Module 1: Hypertension Epidemiology, Screening, and Diagnosis

At the completion of this Application-Based activity, participants will be able to:

  • Describe the impact of hypertension on cardiovascular, kidney, and cognitive health.
  • Recall the incidence and prevalence of hypertension in the United States and the key populations affected.
  • Review the pharmacist’s role in chronic disease management and evidence supporting pharmacy-based interventions.
  • Identify proper blood pressure measurement techniques, including the use of a validated blood pressure cuff.
  • Identify new and ongoing recommendations within the updated 2025 AHA/ACC Guideline for the screening and diagnosis of high blood pressure in adults.
Module 2: Uncomplicated Hypertension Treatment

At the completion of this Application-Based activity, participants will be able to:

  • Identify new and ongoing recommendations within the updated 2025 AHA/ACC Guideline for the management of high blood pressure in adults.
  • Compare and contrast evidence-based antihypertensive medications and their role in therapy.
  • Select appropriate first-line antihypertensive therapy based on individual patient characteristics.
  • Employ patient education strategies on adherence and lifestyle modifications.
Module 3: Advanced Hypertension Treatment

At the completion of this Application-Based activity, participants will be able to:

  • Identify new and ongoing recommendations within the updated 2025 AHA/ACC Guideline for the management of high blood pressure in adults with common comorbidities.
  • Apply evidence-based strategies to address and manage treatment resistant hypertension.
  • Compare and contrast evidence-based antihypertensive medications and their place in therapy.
  • Select an appropriate antihypertensive therapy based on the individual patient’s characteristics and comorbidities.
  • Employ patient education strategies on adherence and the importance of home blood pressure monitoring.
Module 4: Hypertension Management: Monitoring and Follow-up

At the completion of this Application-Based activity, participants will be able to:

  • Compare strategies for continuous home blood pressure monitoring to assess treatment effectiveness.
  • Develop individualized monitoring plans that incorporate treatment goals and potential barriers to care.
  • Modify antihypertensive therapy to address ongoing patient needs, including resistant hypertension, medication nonadherence, and comorbidities.
  • Apply team-based care strategies to support ongoing monitoring, patient education, and timely intervention for hypertension management.
Module 5: Program Design and Business Planning

At the completion of this Knowledge-Based activity, participants will be able to:

  • Identify community- and pharmacy-based metrics to evaluate the plausibility of a pharmacy-based hypertension program.
  • Describe components of an effective, efficient pharmacy workflow for hypertension service delivery.
  • Identify best practices and resources for staff training prior to delivering hypertension services.
  • Discuss the impact of legislative authority on pharmacist-led hypertension services.
Module 6: Program Sustainability

At the completion of this Knowledge-Based activity, participants will be able to:

  • Identify opportunities for pharmacy payment for pharmacy-based hypertension services.
  • Review pharmacists’ medical billing, collaborative practice, contracting, and direct billing models.
  • Describe best practices in billing for pharmacy-based hypertension services, including appropriate billing codes and documentation.

How to Obtain a Certificate of Completion
  • Complete six self-study modules, each of which consists of an interactive eLearning module and an assessment, with a final evaluation at the end of the course.
  • Achieve a passing grade of 70% or higher on each module assessment.
  • Credit must be claimed for each module in order to obtain credit.
  • Participants will need to have a valid APhA (pharmacist.com) username and password, as well as a CPE Monitor account to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
  • The Certificate of Completion will be available online upon successful completion of all six module activities on the participant’s My Training page.
  • APhA continuing pharmacy education policy provides you with two opportunities to successfully complete a continuing pharmacy education assessment. Please note that you will not be permitted to submit an assessment a third time. The current policy of the APhA Education Department is not to release the correct answers to any of our CPE tests. This is intended to maintain the integrity of the CPE activity and the assessment.
Accreditation Information

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. APhA's Pharmacy-Based Hypertension Management is approved for a total of [6.0] contact hours of continuing pharmacy education (CPE) credit (0.6 CEUs). The ACPE Universal Activity Numbers (UAN) for this activity are listed below.

  • ACPE UAN: 0202-0000-26-262-H01-P
  • Target audience: Pharmacists
  • Release date: June 30, 2026
  • Expiration date: June 30, 2029 - PLEASE NOTE: NO Home Study credit granted after this date.
Technology Requirements and Tips

Computer and internet access are required to complete this activity. If you experience technical difficulties, try a different web browser.

Please be aware that if the system detects no activity for an extended amount of time while the screen is open in the interactive activity, the Next button may freeze, and you will need to Restart that activity again.

The recommendation is that if you cannot complete the activity within one sitting and need to step away, close the activity so that your place is bookmarked.

If you continue to experience difficulties, please reach out to education@aphanet.org with the name of course, detail of your experience, which web browser(s) used, and if possible, screenshots.


Development

Pharmacy-Based Hypertension Management was developed by the American Pharmacists Association. Copyright © 2026 by the American Pharmacists Association.
All individuals involved in the development of this material declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For complete APhA staff disclosures, please see the Education and Accreditation Information section at APhA Staff Disclosures.

Faculty

Course Authors:

Sarah J Billups, PharmD, BCPS, FCCP

Associate Professor, Director of Population Health Pharmacy
Skaggs School of Pharmacy and Pharmaceutical Sciences
Aurora, CO

Disclosure: Author has nothing to disclose

Joseph Saseen, PharmD, BCPS, BCACP, CLS

Associate Dean for Clinical Affairs and Professor
University of Colorado Anshutz
Aurora, CO

Disclosure: Amgen, member of data safety monitoring board for CV outcomes trials

Dave L. Dixon, PharmD, FACC, FAHA, FCCP, FNLA, BCACP, CLS

Nancy and Ronald McFarlane Professor of Pharmacy, Chair, Department of Pharmacotherapy and Outcomes Science
Virginia Commonwealth University School of Pharmacy
Richmond, VA

Disclosure: Innovations Horizon, consultant (honoraria)

Cody Clifton, PharmD

Director of Practice Transformation and Clinical Programs
CPESN USA
Savannah, GA

Disclosure: NCPA, speaker (honoraria); University of Georgia College of Pharmacy, speaker (honoraria)

Laura Rhodes, PharmD, BCACP

Assistant Professor, Assistant Director, PGY1 Community-based Pharmacy Residency Program
UNC Eshelman School of Pharmacy
Chapel Hill, NC

Disclosure: Wolters Kleuwer, Consultant (per diem); CPESN, consultant (Stipend)

Advisory Board:

Joseph Saseen, PharmD, BCPS, BCACP, CLS

Associate Dean for Clinical Affairs and Professor
University of Colorado Anshutz
Aurora, CO

Disclosure: Amgen, member of data safety monitoring board for CV outcomes trials

Dave L. Dixon, PharmD, FACC, FAHA, FCCP, FNLA, BCACP, CLS

Nancy and Ronald McFarlane Professor of Pharmacy, Chair, Department of Pharmacotherapy and Outcomes Science
Virginia Commonwealth University School of Pharmacy
Richmond, VA

Disclosure: Innovations Horizon, consultant (honoraria)

Laura Rhodes, PharmD, BCACP

Assistant Professor, Assistant Director, PGY1 Community-based Pharmacy Residency Program
UNC Eshelman School of Pharmacy
Chapel Hill, NC

Disclosure: Wolters Kleuwer, Consultant (per diem); CPESN, consultant (Stipend)